Not this nonsense again. Jonny just stop. It's not going to $20 anytime soon and you know it. With six years of work needed to perform the REQUIRED SPA trials and no money to initiate them in the first place $20 isn't going to happen any time soon if at all. Stop being a desperate troll.
Why don't you stop spouting nonsense? There is NO REQUIREMENT to run the SPA trials for HF, unless they want the product label to indicate Gencaro for heart failure.
Much like the uninformed and ignorant Chunks, you do not seem to have kept up with ABIO's evolving strategy. Let me summarize so that you do not have to actually read the latest 10Q.
The company is now pursuing approval for Gencaro for AF (atrial fibrillation for the morons like you and Chunks). They believe they can gain approval (for AF, not HF, in case you're having problems keeping up) via a 2 year, 300 patient study.
If they can negotiate a reasonable SPA for a 300 patient AF trial, that may be the porkchop they need to attract the big dogs.
You can expect a big pop in the price per share if they can get a SPA for an AF trial.